Business Wire

Alpha Cognition Provides Business Update

VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders provides a business update on it’s ALPHA-1062 NDA filin

More

RTW Charitable Foundation Announces Six Research Grant Recipients

NEW YORK--(BUSINESS WIRE)--RTW Charitable Foundation (“RTWCF”) announced today that it has awarded $900,000 in research grants to support six research studies. These studies aim to drive transformational progress in genetic therapies and align with RT

More

HTuO Biosciences Joins Johnson & Johnson Innovation - JLABS

HTuO Biosciences, a computational drug discovery biotechnology company, is pleased to announce joining Johnson & Johnson Innovation – JLABSVANCOUVER, British Columbia--(BUSINESS WIRE)--#drugdevelopment--HTuO Biosciences, a biotechnology company dev

More

Repare Therapeutics to Regain Global Rights to Camonsertib

Repare will regain control of its potential best-in-class oral small molecule ATR inhibitorCAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncol

More

Oragenics, Inc. Announces Leadership Transition

SARASOTA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (the “Company”), a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders, today announced that, on February 12,

More